acanthosis nigricans
Information
- Disease name
- acanthosis nigricans
- Disease ID
- DOID:3138
- Description
- "A pigmentation disease characterized by velvety, darkening of the skin usually in intertriginous areas." [url:https\://pubmed.ncbi.nlm.nih.gov/32516476/, url:https\://www.ncbi.nlm.nih.gov/books/NBK431057/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05457439 | Active, not recruiting | N/A | Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment | October 1, 2022 | December 2023 |
NCT06008327 | Completed | N/A | Comparison Of Outcome Of Treatment OF Topical 15%TCA VS Topical 0.05% Tretinoin In Treatment Of Acanthosis Nigricans | August 1, 2022 | June 20, 2023 |
NCT00004311 | Completed | Phase 2 | Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome | July 1989 | January 1996 |
NCT02604095 | Completed | N/A | Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism | May 2014 | October 2015 |
NCT01125150 | Completed | Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia | February 2009 | June 2012 | |
NCT01881373 | Completed | N/A | Children's Healthy Living Community Randomized Trial | November 2012 | March 2020 |
NCT06331819 | Recruiting | Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms. | March 10, 2024 | March 1, 2025 | |
NCT06213987 | Recruiting | Phase 3 | The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis Nigricans | February 1, 2024 | May 2024 |
NCT05529563 | Recruiting | The Effect of Laparoscopic Sleeve Gastrectomy on Insulin Secretion Pattern in Morbidly Obese Patients With Acanthosis Nigricans | June 1, 2017 | October 31, 2022 | |
NCT04893304 | Unknown status | N/A | Study of the Effect of Fractional co2 Laser Versus Q Switched:NdYAG Laser in the Treatment of Acanthosis Nigricans | May 30, 2021 | April 30, 2022 |
NCT02438020 | Unknown status | Phase 4 | Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity | June 2015 | October 2016 |
NCT00000112 | Unknown status | Prevalence of Carbohydrate Intolerance in Lean and Obese Children |
- Disase is a (Disease Ontology)
- DOID:10123
- Cross Reference ID (Disease Ontology)
- GARD:8603
- Cross Reference ID (Disease Ontology)
- ICD10CM:L83
- Cross Reference ID (Disease Ontology)
- MESH:D000052
- Cross Reference ID (Disease Ontology)
- MIM:100600
- Cross Reference ID (Disease Ontology)
- MIM:200170
- Cross Reference ID (Disease Ontology)
- NCI:C26687
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:72129000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0000889
- Exact Synonym (Disease Ontology)
- keratosis nigricans
- HPO alt_id (Human Phenotype Ontology)
- HP:0007498
- HPO alt_id (Human Phenotype Ontology)
- HP:0007518
- HPO alt_id (Human Phenotype Ontology)
- HP:0007591
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000956
- ICD10 preferred id (Insert disease from ICD10)
- D0009948
- ICD10 class code (Insert disease from ICD10)
- L83
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000052